Breakfast for Young Women (GoDag)

May 8, 2024 updated by: University of Aarhus
Investigators will in a crossover study test the health effects of eating a dairy-based protein-rich breakfast, isocaloric carbohydrate-rich breakfast or no breakfast in young overweight women. Determination of satiety and hunger using visual analog scores (VAS), collection of blood samples and 2x 24 hours food logs will be collected.

Study Overview

Detailed Description

This study is a single-blind randomized Cross-Over trial with 30 women aged 18-30 years, each completing three trials. Participants will consume either dairy-based protein-rich breakfast, isocaloric, fiber matched, fat matched, carbohydrate-rich breakfast or no breakfast in randomized order. Three hours later a standardized ad libitum lunch will be served.

Blood samples will be collected (pre, 10 min, 30 min, 60 min, 120 min, 175 min after breakfast) and VAS rating hunger, satiety and desire to eat will be determined (pre, during breakfast, 10, 30, 60, 90, 120, 180 min, during lunch, after lunch). Twenty-four hour food logs on the day before the test day and on the test day will be collected.

Participants will be characterized by determining height (cm), weight (kg), and body composition by a dual-energy X-ray (DXA) scan before the first test day.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aarhus, Denmark, 8000
        • Aarhus University, Department for Public Health, Section for Sport Science

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Body mass index > 25
  • Age 18-25 years
  • Regular exercise < 5 hour per week

Exclusion Criteria:

  • illness and use of medication affecting the study outcomes
  • allergy towards lactose or gluten
  • weightloss/gain >5kg the last 6 months
  • dieting
  • eating disorder
  • pregnancy
  • breast feeding
  • unable to speak and understand danish

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High protein breakfast
Participants will be served a dairy-based protein-rich breakfast meal.

High protein yoghurt containing approx. 10 g protein per 100 g. Participants will be asked to consume 300 g (=3 dl) yoghurt with 40 g oats for breakfast.

1 glas of water (150 ml)

Experimental: High carbohydrate breakfast
Participants will be served a carbohydrate-rich breakfast meal

Low protein breakfast containing approx. 2 g protein per 100 g. Participants will be asked to consume ~60 g bread, 20 g jam and 250 ml juice for breakfast.

1 glas of water (150 ml)

Experimental: No breakfast
Participants will be served no breakfast
1 glas of water (150 ml)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Energy consumption on test days
Time Frame: 0-24 hours
Total energy consumption on test days (24 hour food log)
0-24 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in hunger
Time Frame: 0-3 hours
Visual Analog Scale (10 cm) score for feeling of hunger
0-3 hours
Change in satiety
Time Frame: 0-3 hours
Visual Analog Scale (10 cm) score for feeling of satiety
0-3 hours
change in desire
Time Frame: 0-3 hours
Visual Analog Scale (10 cm) score for feeling of desire to eat
0-3 hours
Change in ghrelin
Time Frame: 0-3 hours
in blood sample
0-3 hours
Change in leptin
Time Frame: 0-3 hours
in blood sample
0-3 hours
Change in glucose-dependent insulinotropic polypeptide (GIP)
Time Frame: 0-3 hours
in blood sample
0-3 hours
Change in Peptide YY (PYY3-36)
Time Frame: 0-3 hours
in blood sample
0-3 hours
Change in insulin
Time Frame: 0-3 hours
in blood sample
0-3 hours
Change in glucagon
Time Frame: 0-3 hours
in blood sample
0-3 hours
Change in glucose
Time Frame: 0-3 hours
in blood sample
0-3 hours
Energy consumption the day before a test day (food registration)
Time Frame: 0-24 hours
Total energy consumption on the day before the test day
0-24 hours

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Height
Time Frame: Baseline
Height in cm
Baseline
Weight
Time Frame: Baseline
Weight in kg
Baseline
Body composition fat
Time Frame: Baseline
DXA-scanning to determine fat mass
Baseline
Body composition fat free
Time Frame: Baseline
DXA-scanning to determine fat free mass
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mette Hansen, Assoc Prof, University of Aarhus

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 24, 2020

Primary Completion (Actual)

September 1, 2022

Study Completion (Actual)

November 21, 2023

Study Registration Dates

First Submitted

November 26, 2020

First Submitted That Met QC Criteria

November 26, 2020

First Posted (Actual)

December 3, 2020

Study Record Updates

Last Update Posted (Actual)

May 9, 2024

Last Update Submitted That Met QC Criteria

May 8, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Protein-rich breakfast

Subscribe